Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

"Timolol in essential hypertension" a preliminary report.

B Okuwobi, O Ogunyemi

    West African Journal of Pharmacology and Drug Research
    |June 1, 1977
    PubMed
    Summary

    Timolol, a new beta-adrenergic blocking drug, effectively lowers blood pressure in patients with essential hypertension. Most patients experienced satisfactory results, with bradycardia being the main side effect observed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Finding appropriate clinical trials: evaluating encoded eligibility criteria with incomplete data.

    Proceedings. AMIA Symposium·2002
    Same author

    Using features of Arden Syntax with object-oriented medical data models for guideline modeling.

    Proceedings. AMIA Symposium·2002
    Same author

    Toward a representation format for sharable clinical guidelines.

    Journal of biomedical informatics·2001
    Same author

    TraumaSCAN: assessing penetrating trauma with geometric and probabilistic reasoning.

    Proceedings. AMIA Symposium·2000
    Same author

    GLIF3: the evolution of a guideline representation format.

    Proceedings. AMIA Symposium·2000
    Same author

    Probabilistic predictions of penetrating injury to anatomic structures.

    Proceedings : a conference of the American Medical Informatics Association. AMIA Fall Symposium·1997

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Essential hypertension is a widespread condition requiring effective treatment.
    • Beta-adrenergic blocking agents are a key class of antihypertensive medications.

    Purpose of the Study:

    • To evaluate the efficacy and safety of Timolol (Blocadren) in treating essential hypertension.

    Main Methods:

    • A clinical trial involving twelve previously untreated patients with essential hypertension.
    • Administration of Timolol twice daily.

    Main Results:

    • A significant reduction in systolic and diastolic blood pressure was observed in eleven out of twelve patients.
    • One patient was withdrawn due to excessive bradycardia.
    • No other serious adverse effects were reported.

    Conclusions:

    • Timolol demonstrates promising efficacy in managing essential hypertension.
    • Further long-term studies are recommended to establish Timolol's role in antihypertensive therapy.

    Related Experiment Videos